US Patent Issued to PHARMA CINQ on Aug. 11 for "Compositions and compounds for co-delivery of uridine and ketoleucine" (Maryland Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,718, issued on Aug. 11, was assigned to PHARMA CINQ LLC (Rockville, Md.).

"Compositions and compounds for co-delivery of uridine and ketoleucine" was invented by Reid Warren Von Borstel (Potomac, Md.), David Michael Simpson (North Bethesda, Md.) and Rolando Alejandro Garcia Garcia (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and compositions that deliver both uridine and ketoleucine are useful in treating disorders characterized by diminished muscle strength or diminished muscle lean mass. One such a compound is 5'-O-ketoleucyl-2',3'-di-O-acetyluridine."

The patent was filed on Feb. 2, 2022, under Application No. 18/547...